Pharma Journalist -

Shire announces that the Marketing Authorization Application (MAA) for lifitegrast, submitted on 07 August 2017, has been validated by the UK as the Reference Member State involved in…
Read More...

Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient enrichment, today…
Read More...

Regeneron Pharmaceuticals announced that a Phase 3 study evaluating suptavumab (REGN2222), an antibody to respiratory syncytial virus (RSV), did not meet its primary endpoint of…
Read More...

After a series of thorough tests with the European Medicines Verification Organization (EMVO) for connection to the European Hub, Adents is now one of only two official “Certified…
Read More...

Array BioPharma, a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer,…
Read More...

A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene and cell therapy manufacturing. Other partners include the Cell and Gene…
Read More...

Takeda Pharmaceutical Company Limited announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform…
Read More...

PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds for the treatment of multiple myeloma.…
Read More...

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland Diabetes Care for SNI's lead developmental pain drug TV1001SR- which…
Read More...

Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. "This acquisition is an important component of our…
Read More...